Guggenheim Capital’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,362
| Closed | -$26.9K | – | 1678 |
|
|
2024
Q3 | $26.9K | Sell |
10,362
-922
| -8% | -$2.4K | ﹤0.01% | 1853 |
|
|
2024
Q2 | $33.4K | Sell |
11,284
-260
| -2% | -$770 | ﹤0.01% | 1850 |
|
|
2024
Q1 | $52.3K | Sell |
11,544
-194
| -2% | -$879 | ﹤0.01% | 1857 |
|
|
2023
Q4 | $67K | Sell |
11,738
-457
| -4% | -$2.61K | ﹤0.01% | 1859 |
|
|
2023
Q3 | $56.1K | Buy |
12,195
+283
| +2% | +$1.3K | ﹤0.01% | 1823 |
|
|
2023
Q2 | $77K | Sell |
11,912
-3,049
| -20% | -$19.7K | ﹤0.01% | 1844 |
|
|
2023
Q1 | $113K | Buy |
14,961
+4,337
| +41% | +$32.7K | ﹤0.01% | 1867 |
|
|
2022
Q4 | $108K | Buy |
+10,624
| New | +$108K | ﹤0.01% | 1864 |
|